| Dana P Hawkins, OD | |
|
1 Pinckney Blvd, Beaufort, SC 29902-6122 | |
| (843) 228-5600 | |
| Not Available |
| Full Name | Dana P Hawkins |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 7 Years |
| Location | 1 Pinckney Blvd, Beaufort, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700303807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901005052 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Vision Center Inc | 8426209107 | 3 |
News Archive
A new study suggests an additional-and somewhat surprising-potential benefit of vaccinating children against rotavirus, a common cause of diarrhea and vomiting. Besides protecting kids from intestinal illness caused by rotavirus, immunization may also reduce the risk of related seizures, according to findings published in Clinical Infectious Diseases and available online.
Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.
Increases in temperatures as a result of climate change is favoring the transmission of the West Nile Virus (WNV) in parts of Europe, by creating more suitable conditions for the virus and its mosquito vectors to proliferate.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 1 days ago
| Provider Name | Southwest Vision Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1871852939 PECOS PAC ID: 8426209107 Enrollment ID: O20121105000554 |
News Archive
A new study suggests an additional-and somewhat surprising-potential benefit of vaccinating children against rotavirus, a common cause of diarrhea and vomiting. Besides protecting kids from intestinal illness caused by rotavirus, immunization may also reduce the risk of related seizures, according to findings published in Clinical Infectious Diseases and available online.
Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.
Increases in temperatures as a result of climate change is favoring the transmission of the West Nile Virus (WNV) in parts of Europe, by creating more suitable conditions for the virus and its mosquito vectors to proliferate.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dana P Hawkins, OD 9620 E Eaton Hwy, Mulliken, MI 48861-9645 Ph: (517) 819-7769 | Dana P Hawkins, OD 1 Pinckney Blvd, Beaufort, SC 29902-6122 Ph: (843) 228-5600 |
News Archive
A new study suggests an additional-and somewhat surprising-potential benefit of vaccinating children against rotavirus, a common cause of diarrhea and vomiting. Besides protecting kids from intestinal illness caused by rotavirus, immunization may also reduce the risk of related seizures, according to findings published in Clinical Infectious Diseases and available online.
Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.
Increases in temperatures as a result of climate change is favoring the transmission of the West Nile Virus (WNV) in parts of Europe, by creating more suitable conditions for the virus and its mosquito vectors to proliferate.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 1 days ago
Niko Olavi Vahamaki, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Pinckney Blvd, Beaufort, SC 29902 Phone: 843-228-5478 | |
Dr. Richard Wan, OD, MS Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd, Beaufort, SC 29902 Phone: 843-228-5200 | |
Eye Care One Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11 Robert Smalls Pkwy, Suite H, Beaufort, SC 29906 Phone: 843-524-8302 | |
Thomasvtran, Od, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 350 Robert Smalls Pkwy, Beaufort, SC 29906 Phone: 843-522-9755 Fax: 843-521-3085 | |
Shell Point Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 204 Midtown Dr, Beaufort, SC 29906 Phone: 843-521-4037 Fax: 843-521-0138 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 204 Midtown Dr, Beaufort, SC 29906 Phone: 843-521-4037 | |
Dr. Raymond Ellsworth Jimison Ii, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11 Robert Smalls Pkwy, Beaufort, SC 29906 Phone: 843-524-8302 Fax: 843-379-5974 |